Skip to main content
MYUNGMOON PHARM CO.,LTD logo

MYUNGMOON PHARM CO.,LTD — Investor Relations & Filings

Ticker · 017180 ISIN · KR7017180001 KO Manufacturing
Open in API
Filings indexed 250 across all filing types
Latest filing 2021-11-04 M&A Activity
Country KR South Korea
Listing KO 017180

About MYUNGMOON PHARM CO.,LTD

http://mmpharm.co.kr/en/main/

Myungmoon Pharm Co., Ltd. is a research-based pharmaceutical company engaged in the development, manufacturing, and commercialization of healthcare products. The company produces over 250 specialized and general medicines, holding more than 400 manufacturing licenses. Its portfolio includes both ethical (ETC) and over-the-counter (OTC) drugs, with key product areas in anesthetics, digestive agents, and antitussives. The company's operations encompass the wholesale, import, and export of its pharmaceutical products for domestic and international markets.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항
M&A Activity Classification · 100% confidence The document is a regulatory filing from a Korean company (Myungmoon Pharm) regarding the selection of a preferred bidder for the sale of a major shareholder's stake. This type of corporate disclosure regarding M&A activity, specifically the selection of a preferred bidder for a potential takeover or stake sale, falls under the M&A Activity category.
2021-11-04 Korean
조회공시요구(풍문또는보도)에대한답변(미확정)
Regulatory Filings Classification · 100% confidence The document is a response to a regulatory inquiry regarding market rumors about a major shareholder stake sale. It is a formal regulatory announcement issued by the company to clarify its position on a potential transaction. Since it does not fit into specific categories like M&A (which usually involves definitive agreements) or other financial reports, and serves as a general regulatory disclosure, it is classified as a Regulatory Filing (RNS).
2021-11-04 Korean
조회공시요구(풍문또는보도)
Regulatory Filings Classification · 100% confidence The document is a short regulatory notice from the Korea Exchange requesting a clarification from Myungmoon Pharm regarding rumors of a major shareholder stake sale. It is a standard regulatory inquiry/announcement rather than a financial report or M&A agreement itself, fitting best under the general regulatory filings category.
2021-11-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details a specific transaction (a sale of 1,000 shares) by an executive (Choi Heung-mook) of Myungmoon Pharm. This type of filing, which reports personal share transactions by company directors and executives, is classified as 'Director's Dealing'.
2021-10-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (Korea). It details the share transactions (specifically a sale of shares) by an executive (Choi Heung Mook) of Myungmoon Pharm. This type of filing is categorized as 'Director's Dealing' (DIRS) as it reports personal share transactions by company insiders.
2021-09-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the change in share ownership by an executive (Choi Heung-mook) of Myungmoon Pharm. This type of filing is specifically for reporting insider transactions (director/executive dealings) to the financial regulatory authorities.
2021-09-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.